Statistics
Publications
25
Citations
1.6K
H-Index
20
Active since
2012
Shengzhe Zhang is an author at Shanghai Jiao Tong University specializing in oncology, molecular oncology, and medicine.
Publications per year
2012–2024
25
25
Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors
Shengzhe Zhang, Meiying Zhang, Ying Jing et al. · Nature Communications · 2018 · 154 citations · Full text
BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1
Zhenfeng Zhang, Pengfei Ma, Ying Jing et al. · Theranostics · 2015 · 100 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 25